ArticleSeminars in arthritis and rheumatism2024

Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer.

Kaitlin R McCarter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.